苏俊秀?徐屹?康旭

    【摘要】 芍倍注射液是一种软化萎缩剂，可用于治疗腋臭，不良反应极少。脂膜炎是累及皮下脂肪层的一类皮肤病。该文报道1例接受芍倍注射术后继发脂膜炎的病例。该例为37岁女性，接受了双侧腋窝芍倍注射术，术后8 d左侧腋窝出现皮下结节，并伴有疼痛，后皮下脂肪发生液化坏死，经切开引流后痊愈，病灶处皮下组织病理学检查示变性坏死的纤维脂肪组织，确诊为脂膜炎。该例提示，虽然芍倍注射液的不良反应极少，但在被用于治疗腋臭时仍有可能引发脂膜炎，芍倍注射术后继发脂膜炎时应充分引流，及时清除病灶。

    【关键词】 腋臭;芍倍注射液;脂膜炎

    A case of axillary osmidrosis developing panniculitis after Shaobei injection Su Junxiu△， Xu Yi， Kang Xu.△The Second Clinical Medical School，Guangzhou University of Chinese Medicine，Guangzhou 510006，China

    Corresponding author， Kang Xu， E-mail： Kangxuwf@163.com

    【Abstract】 Shaobei injection is a softening and shrinking agent， which is applied to treat axillary osmidrosis and rarely causes adverse reactions. Panniculitis is a skin disease that involves the subcutaneous fat layer. In this article， one case of panniculitis secondary to Shaobei injection was reported. The 37-year-old female patient developed left-sided subcutaneous nodules complicated with pain at 8 d after Shaobei injection. Subsequently， subcutaneous fat liquefaction and necrosis occurred ......